Miriam Redondo

959 total citations
25 papers, 808 citations indexed

About

Miriam Redondo is a scholar working on Molecular Biology, Pharmacology and Immunology. According to data from OpenAlex, Miriam Redondo has authored 25 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Pharmacology and 6 papers in Immunology. Recurrent topics in Miriam Redondo's work include Phosphodiesterase function and regulation (13 papers), Cholinesterase and Neurodegenerative Diseases (9 papers) and Mast cells and histamine (5 papers). Miriam Redondo is often cited by papers focused on Phosphodiesterase function and regulation (13 papers), Cholinesterase and Neurodegenerative Diseases (9 papers) and Mast cells and histamine (5 papers). Miriam Redondo collaborates with scholars based in Spain, United Kingdom and United States. Miriam Redondo's co-authors include Carmen Gil, Ana Martı́nez, Ciara K. O’Sullivan, Concepción Pérez, Daniel I. Pérez, Ana Pérez‐Castillo, José Á. Morales-García, Sandra Alonso‐Gil, Alessandro Pinto and Paul J. Ciclitira and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Analytical Chemistry.

In The Last Decade

Miriam Redondo

24 papers receiving 794 citations

Peers

Miriam Redondo
H Hidaka Japan
Miriam Redondo
Citations per year, relative to Miriam Redondo Miriam Redondo (= 1×) peers H Hidaka

Countries citing papers authored by Miriam Redondo

Since Specialization
Citations

This map shows the geographic impact of Miriam Redondo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miriam Redondo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miriam Redondo more than expected).

Fields of papers citing papers by Miriam Redondo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miriam Redondo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miriam Redondo. The network helps show where Miriam Redondo may publish in the future.

Co-authorship network of co-authors of Miriam Redondo

This figure shows the co-authorship network connecting the top 25 collaborators of Miriam Redondo. A scholar is included among the top collaborators of Miriam Redondo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miriam Redondo. Miriam Redondo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Redondo, Miriam, et al.. (2025). Aptamer lateral flow assay for the rapid detection of histamine in fish and human blood. Journal of Hazardous Materials. 494. 138540–138540. 2 indexed citations
3.
Borrás, Aina, Pilar Carrillo, Sara Peralta, et al.. (2023). Current status of fertility preservation in a Spanish tertiary public hospital: multidisciplinary approach and experience in over 1500 patients. Clinical & Translational Oncology. 26(5). 1129–1138. 1 indexed citations
4.
Andreu, Alba, Miriam Redondo, Ferràn Torres, et al.. (2021). Bariatric Surgery on Reproductive Outcomes: the Impact According to the Diagnosis of Polycystic Ovarian Syndrome and Surgical Procedures. Obesity Surgery. 31(6). 2590–2598. 10 indexed citations
5.
Mestre, Leyre, Miriam Redondo, Francisco J. Carrillo‐Salinas, et al.. (2015). PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosis. British Journal of Pharmacology. 172(17). 4277–4290. 32 indexed citations
6.
García, Ana M., Miriam Redondo, Ana Martı́nez, & Carmen Gil. (2014). Phosphodiesterase 10 Inhibitors: New Disease Modifying Drugs for Parkinson’s Disease?. Current Medicinal Chemistry. 21(10). 1171–1187. 24 indexed citations
7.
Salado, Irene G., Miriam Redondo, Murilo Lamim Bello, et al.. (2014). Protein Kinase CK-1 Inhibitors As New Potential Drugs for Amyotrophic Lateral Sclerosis. Journal of Medicinal Chemistry. 57(6). 2755–2772. 92 indexed citations
8.
Medina‐Rodríguez, Eva M., Francisco Javier Arenzana, Jesús Pastor, et al.. (2013). Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival. Cellular and Molecular Life Sciences. 70(18). 3449–3462. 50 indexed citations
9.
Redondo, Miriam, Ignacio Soteras, José Brea, et al.. (2013). Unraveling phosphodiesterase surfaces. Identification of phosphodiesterase 7 allosteric modulation cavities. European Journal of Medicinal Chemistry. 70. 781–788. 4 indexed citations
10.
Pinto, Alessandro, Pedro Nadal, Olivier Henry, et al.. (2013). Label-free detection of gliadin food allergen mediated by real-time apta-PCR. Analytical and Bioanalytical Chemistry. 406(2). 515–524. 39 indexed citations
11.
Pérez‐González, Rocío, Consuelo Pascual, Desireé Antequera, et al.. (2013). Phosphodiesterase 7 inhibitor reduced cognitive impairment and pathological hallmarks in a mouse model of Alzheimer's disease. Neurobiology of Aging. 34(9). 2133–2145. 79 indexed citations
12.
González‐García, Coral, Beatriz Bravo, Alicia Ballester, et al.. (2013). Comparative assessment of PDE 4 and 7 inhibitors as therapeutic agents in experimental autoimmune encephalomyelitis. British Journal of Pharmacology. 170(3). 602–613. 44 indexed citations
13.
Martı́nez, Ana, Eva Carro, Carmen Gil, et al.. (2013). O5–06–03: Enhancing brain cAMP trough PDE‐7 inhibitors: A new Alzheimer's disease pharmacotherapy approach. Alzheimer s & Dementia. 9(4S_Part_21). 2 indexed citations
14.
Pérez, Daniel I., Marco Pistolozzi, Valle Palomo, et al.. (2012). 5-Imino-1,2-4-thiadiazoles and quinazolines derivatives as glycogen synthase kinase 3β (GSK-3β) and phosphodiesterase 7 (PDE7) inhibitors: Determination of blood–brain barrier penetration and binding to human serum albumin. European Journal of Pharmaceutical Sciences. 45(5). 677–684. 28 indexed citations
15.
Redondo, Miriam, José Brea, Daniel I. Pérez, et al.. (2012). Effect of Phosphodiesterase 7 (PDE7) Inhibitors in Experimental Autoimmune Encephalomyelitis Mice. Discovery of a New Chemically Diverse Family of Compounds. Journal of Medicinal Chemistry. 55(7). 3274–3284. 51 indexed citations
16.
Morales-García, José Á., Miriam Redondo, Sandra Alonso‐Gil, et al.. (2011). Phosphodiesterase 7 Inhibition Preserves Dopaminergic Neurons in Cellular and Rodent Models of Parkinson Disease. PLoS ONE. 6(2). e17240–e17240. 90 indexed citations
17.
Redondo, Miriam, Juan G. Zarruk, Daniel I. Pérez, et al.. (2011). Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke model. European Journal of Medicinal Chemistry. 47(1). 175–185. 64 indexed citations
18.
Pinto, Alessandro, Miriam Redondo, Veli Cengiz Özalp, & Ciara K. O’Sullivan. (2009). Real-time apta-PCR for 20 000-fold improvement in detection limit. Molecular BioSystems. 5(5). 548–553. 51 indexed citations
19.
Nassef, Hossam M., Miriam Redondo, Paul J. Ciclitira, et al.. (2008). Electrochemical Immunosensor for Detection of Celiac Disease Toxic Gliadin in Foodstuff. Analytical Chemistry. 80(23). 9265–9271. 67 indexed citations
20.
Zeerleder, Sacha, Christoph Caliezi, Miriam Redondo, Jan Devay, & Walter A. Wuillemin. (1999). [Activation of plasma cascade systems in sepsis: role of C1 inhibitors].. PubMed. 129(39). 1410–7. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026